Showing 221-240 of 8668 for: Cochrane Systematic Reviews Back
- Air versus saline in the loss of resistance technique for identification of the epidural space
Cochrane Systematic Reviews, 17-Jul-2014
The success of epidural anaesthesia depends on correct identification of the epidural space. For several decades, the decision of whether to use air or physiological saline during the loss of resistance technique for identification of the epidural space h
- Airway clearance techniques for bronchiectasis
Cochrane Systematic Reviews, 23-Nov-2015
People with non-cystic fibrosis bronchiectasis commonly experience chronic cough and sputum production, features that may be associated with progressive decline in clinical and functional status. Airway clearance techniques (ACTs) are often prescribed to
- Airway clearance techniques for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 2-Feb-2012
Cough and sputum production are common in chronic obstructive pulmonary disease (COPD) and are associated with adverse clinical outcomes. Airway clearance techniques (ACTs) aim to remove sputum from the lungs, however evidence of their efficacy during acu
- Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews
Cochrane Systematic Reviews, 24-Jan-2019
Cystic fibrosis is a life-limiting genetic condition in which thick mucus builds up in the lungs, leading to infections, inflammation, and eventually, deterioration in lung function. To clear their lungs of mucus, people with cystic fibrosis perform airwa
- Airway physical examination tests for detection of difficult airway management in apparently normal adult patients
Cochrane Systematic Reviews, 15-May-2018
The unanticipated difficult airway is a potentially life-threatening event during anaesthesia or acute conditions. An unsuccessfully managed upper airway is associated with serious morbidity and mortality. Several bedside screening tests are used in clini
- Alarm interventions for nocturnal enuresis in children
Cochrane Systematic Reviews, 4-May-2020
Enuresis (bedwetting) affects up to 20% of five-year-olds and can have considerable social, emotional and psychological effects. Treatments include alarms (activated by urination), behavioural interventions and drugs.
- Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis
Cochrane Systematic Reviews, 8-Jan-2019
The Global Programme to Eliminate Lymphatic Filariasis recommends mass treatment of albendazole co-administered with the microfilaricidal (antifilarial) drugs diethylcarbamazine (DEC) or ivermectin; and recommends albendazole alone in areas where loiasis
- Albumin infusion for low serum albumin in preterm newborn infants
Cochrane Systematic Reviews, 12-Apr-2010
Intravenous albumin infusion is used to treat hypoalbuminaemia in critically ill infants. Hypoalbuminaemia occurs in a number of clinical situations including prematurity, respiratory distress syndrome (RDS), chronic lung disease (CLD), necrotising entero
- Alcohol and drug screening of occupational drivers for preventing injury
Cochrane Systematic Reviews, 25-Jan-2009
Workforce alcohol and drug testing is commonplace but its effect in reducing occupational injuries remains unclear.
- Alcohol ignition interlock programmes for reducing drink driving recidivism
Cochrane Systematic Reviews, 19-Jul-2004
An ignition interlock device is part of a multi-dimensional programme aimed at reducing recidivism in convicted drink drivers. To operate a vehicle equipped with an ignition interlock device, the driver must first provide a breath specimen. If the breath
- Alcohol intake reduction for controlling hypertension
Cochrane Systematic Reviews, 21-Sep-2020
High blood pressure constitutes one of the leading causes of mortality and morbidity all over the world. At the same time, heavy drinking increases the risk for developing cardiovascular diseases, including cardiomyopathy, hypertension, atrial arrhythmias
- Alcoholics Anonymous and other 12-step programmes for alcohol dependence
Cochrane Systematic Reviews, 7-May-2009
Alcoholics Anonymous (AA) is an international organization of recovering alcoholics that offers emotional support through self-help groups and a model of abstinence for people recovering from alcohol dependence, using a 12-step approach. Although it is th
- Alcoholics Anonymous and other 12‐step programs for alcohol use disorder
Cochrane Systematic Reviews, 11-Mar-2020
Alcohol use disorder (AUD) confers a prodigious burden of disease, disability, premature mortality, and high economic costs from lost productivity, accidents, violence, incarceration, and increased healthcare utilization. For over 80 years, Alcoholics Ano
- Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy
Cochrane Systematic Reviews, 3-Nov-2008
Diabetic peripheral neuropathy is a common complication of diabetes mellitus.
- Aldose reductase inhibitors for the treatment of diabetic polyneuropathy
Cochrane Systematic Reviews, 17-Oct-2007
Polyneuropathy, a common complication of diabetes mellitus, causes pain and sensory and motor deficits in the limbs, and is also an important independent predictor of foot ulceration. Inhibiting the metabolism of glucose by the polyol pathway using aldose
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis
Cochrane Systematic Reviews, 15-Feb-2021
People with chronic kidney disease (CKD) requiring dialysis are at a particularly high risk of cardiovascular death and morbidity. Several clinical studies suggested that aldosterone antagonists would be a promising treatment option for people undergoing
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
Cochrane Systematic Reviews, 27-Oct-2020
Treatment with angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is used to reduce proteinuria and retard the progression of chronic kidney disease (CKD). However, resolution of proteinuria may be incomplete with thes
- Alemtuzumab for multiple sclerosis
Cochrane Systematic Reviews, 15-Apr-2016
Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating exacerbations, preventing new exacerbations and avoiding th
- Alemtuzumab for patients with chronic lymphocytic leukaemia
Cochrane Systematic Reviews, 15-Feb-2012
Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in Western countries. Standard treatment includes mono- or poly-chemotherapies. Nowadays, monoclonal antibodies are added, especially alemtu
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
Cochrane Systematic Reviews, 27-Nov-2017
Alemtuzumab is a humanised monoclonal antibody that alters the circulating lymphocyte pool, causing prolonged lymphopenia, thus remoulding the immune repertoire that accompanies homeostatic lymphocyte reconstitution. It has been proved more effective than
